Oct 20 (Reuters) – Verrica Pharmaceuticals Inc: * VERRICA PHARMACEUTICALS RECEIVES POSITIVE FEEDBACK FROM THE EUROPEAN MEDICINES AGENCY (EMA) SUPPORTING A CLEAR REGULATORY PATH FORWARD TO FILE FOR APPROVAL OF YCANTH® IN THE EUROPEAN UNION * VERRICA PHARMACEUTICALS INC – PLANS REGULATORY SUBMISSION FOR YCANTH BY Q4 2026 Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Chicago Bears quarterback Tyson Bagent cleared the necessary steps in the concussion protocol to participate…
LONDON, Sept 26 (Reuters) - Mikel Oyarzabal scored the winner as World champions Spain capitalised…
VIDEO SHOWS: HIGHLIGHTS OF DAY 7 OF THE ASIAN GAMES RESENDING WITH COMPLETE SCRIPT SHOWS:…
Eduardo Valencia hit a two-out, two-strike, two-run home run in the ninth inning to lift…
VIDEO SHOWS: VARIOUS STILL PHOTOS OF TRUMP AT THE UNIVERSITY OF TENNESSEE VS. UNIVERSITY OF…
Sep 26 (Stats Perform) - Results from the NCAAF games on Saturday (home team in…